A previous study showed that treatment of 5-AZA-2′-deoxycytidine (5-AZA-CdR) causes a decreased DNMT1 expression and increased p21 expression in colon cancer SW480 cells [49]. Here, DNMT1 is linked to colonic neoplasm.